Epidemiological and Mendelian randomization studies demonstrated that obese patients and patients with T2D present low circulating levels of the cardiac hormone atrial natriuretic peptide (ANP) (2, 3). The gene discussed is NPPA; the disease is type 2 diabetes mellitus.